Patent Assignment
Reel/Frame 058279/0766
Assignment of Assignor's Interest
Recorded: 2021-12-03
Pages: 5
Assignor
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Executed: 2021-11-22
Assignee
PB IMMUNE THERAPEUTICS INC.
RM. 230, GLOBAL CENTER, SEOUL NATIONAL UNIVERSITY MEDICAL COLLEGE, 71 LHWAJANG-GIL, JONGNO-GU, SEOUL, 03087, KOREA, REPUBLIC OF
Covered Property
(1)
Anti-CD40 Antibody and Methods for Blocking CD40-CD40L Signaling
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.